EICHOR
● Active Not Recruiting
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
Condition: Non-small Cell Lung Cancer · Sponsor: Dizal Pharmaceuticals
About this study
This is a phase 3, open-label, randomized, multi-center study assessing the efficacy and safety of DZD9008 versus platinum-based doublet chemotherapy in participants with locally advanced or metastatic NSCLC with EGFR Exon20ins mutation, who are newly diagnosed or have not received prior systemic therapy in advanced stage. Primary objective of this study is to assess the efficacy of DZD9008 versus platinum-based doublet chemotherapy using by BICR-assessed PFS per RECIST 1.1 as primary endpoint. Approximately 320 participants are estimated to be randomized into the study. Participants enrolled will be randomized to DZD9008 or platinum-based doublet chemotherapy in a 1:1 manner, stratified by baseline brain metastasis (with/without).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (158)
| OPN Healthcare, Inc. | Glendale, California, United States | — |
| Kaiser Permanente Medical Center | Vallejo, California, United States | — |
| University of Colorado Hospital - Anschutz Cancer Pavilion | Aurora, Colorado, United States | — |
| D&H Cancer Research Center LLC | Margate, Florida, United States | — |
| BRCR Medical Center Inc. | Plantation, Florida, United States | — |
| NYU Laura & Issac Perlmutter Cancer Center at NYU Langone Health | New York, New York, United States | — |
| Columbia University Medical Center | New York, New York, United States | — |
| Gabrail Cancer Center Research | Canton, Ohio, United States | — |
| OSU Brain & Spine Hospital | Columbus, Ohio, United States | — |
| Providence Portland Institute Franz | Portland, Oregon, United States | — |
| Texas Oncology - Baylor Charles A. Sammons Cancer Center | Dallas, Texas, United States | — |
| The University of Texas MD Anderson cancer center | Houston, Texas, United States | — |
+ 146 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05668988